Clinical trial
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV…
NCT00034190 · Achieve Life Sciences, Industry · Completed
Key facts
| NCT number | NCT00034190 |
|---|---|
| Title | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma |
| Official title | A Phase IIa Multicenter Evaluation of The Safety And Efficacy of Weekly Administration of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment of Patients With Stage III or IV Colorectal Adenocarcinoma |
| Lead sponsor | Achieve Life Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Adenocarcinoma |
| Intervention type | Drug |
| Interventions | S-8184 Paclitaxel Injectable Emulsion |
| Enrollment | 28 |
| Start date | Mar 1, 2002 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 25, 2002 |
| Last update posted | Jun 4, 2009 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: